Company Info






  Home > Archived Webinars > Medical Device >

Coding and Payment for Oncology Diagnostics



 
Our Price: $395.00

Product Code: WB-7014
Qty:

Product Info
 
About the Product
Contains video file.


The demand for cancer diagnostics has sky rocketed in the past decade with expected revenue of $5.3 billion by 2015 according to industry analysts. Additionally, the US diagnostic reimbursement environment has evolved with the government now heavily influencing payer coverage decisions and ultimately driving cancer diagnostics decisions to evolve from a subjective coding system to one which requires the demonstration of clinical utility. Prior to the creation of the AMA's CPT codes for molecular and diagnostics in 2012, a number of cancer diagnostics were reimbursed under "stacking codes" based off the tests' methods versus the use of a specified analyte. The creation of CPT codes specific to molecular diagnostics aims to reduce variations in coding and take into account the tests' clinical effect which will enable payers have a greater understanding of what they are paying for and the value behind it.
  • Navigating the changes in the molecular diagnostic coding
  • Discussing evidence models for cancer diagnostics
  • Imbedding evidence generation into the cancer diagnostic test development process

Speaker:
John Ridge
Director of Reimbursement Services
Ventana Roche


Target Audience
  • Reimbursement
  • Government Affairs
  • Health Economics
  • Coding and Billing
  • Market Access
  • Oncology Strategy

Target Industry
  • Diagnostic Manufacturers
  • Organizations Interested in Partnering on Personalized Oncology Diagnostics

Share your knowledge of this product. Be the first to write a review »